Novak Djokovic has a majority stake in a Danish biotechnology agency making an attempt to develop a therapy for Covid-19, it has emerged.
The world primary is at the moment again in Belgrade after he was deported from Australia after failing to realize a visa to enter the nation for the Australian Open.
QuantBioRes boss Ivan Loncarevic has revealed that the tennis participant’s acquisition of the 80 per cent stake was made in June 2020 however declined to say how a lot it was.
The corporate is growing a peptide, which inhibits the coronavirus from infecting the human cell, and expects to launch scientific trials in Britain this summer time, in accordance with Loncarevic, who confused the agency was engaged on a therapy, not a vaccine.
The CEO mentioned the corporate had a few dozen researchers working in Denmark, Australia and Slovenia. In accordance with the Danish firm register, Djokovic and his spouse Jelena personal 40.8% and 39.2% of the corporate, respectively.
A spokesperson for Djokovic didn’t instantly reply to a request for remark.
Djokovic has loved phenomenal success but time will not be on the world primary’s aspect in his quest to be considered as the best participant is historical past, as he advances deeper into his 30s.
He had desperately hoped to play in Australian Open this month together with his sights firmly set on netting a twenty first grand slam title, which might transfer him above archrivals Roger Federer and Rafa Nadal.
However following his troubles in Australia a annoyed Djokovic now dangers being frozen out elsewhere with guidelines on travellers who’re unvaccinated tightening within the third yr of the pandemic and a few tournaments reconsidering exemptions.
Probably the most speedy concern is the following grand slam – the French Open in Could the place Nadal has already amassed a staggering 13 titles – after the nation’s sports activities ministry mentioned on Monday there can be no exemption from a brand new vaccine move regulation.
Kaynak: briturkish.com
